Oliver McGowan: new training guidelines launched | Nursing Times
Read about a new code of practice to help employers deliver the Oliver McGowan learning disability and autism training.
Read about a new code of practice to help employers deliver the Oliver McGowan learning disability and autism training.
Dr. Rita Mukhtar and Dr. Joshua K. Sabari discuss the role of ctDNA to guide surgical decision-making after neoadjuvant chemo in breast cancer treatment.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing safety/activity with novel therapies.
Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the RESILIENT-1 and NeoADAURA trials.
Surviving cancer wasn’t the end of my story; it was the start of redefining life, finding purpose and offering hope to those walking behind me.
FDA approves updated labeling for Talzenna plus Xtandi in men with HRR gene-mutated metastatic prostate cancer, showing a 14-month survival benefit.
The Terminally Ill Adults (End of Life) Bill has passed the House of Commons and will now progress to the House of Lords. Read more.
The Terminally Ill Adults (End of Life) Bill has passed the House of Commons and will now progress to the House of Lords. Read more.
Read about why maternity services at Leeds Teaching Hospitals NHS Trust have been downgraded from good to inadequate.
Read about why maternity services at Leeds Teaching Hospitals NHS Trust have been downgraded from good to inadequate.